Reduced Venous Blood Basophil Count and Anxious Depression in Patients with Major Depressive Disorder
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
ObjectiveaaAnxious depression has a distinct neurobiology, clinical course and treatment response from non-anxious depression. Role of inflammation in anxious depression has not been examined. As an exploratory study to characterize the role of inflammation on a development of anxious depression, we aimed to determine the relationship between white blood cell (WBC) subset counts and anxiety in individuals with major depressive disorder (MDD). MethodsaaA total of 709 patients who were newly diagnosed with MDD were recruited. Anxiety levels of participants were evaluated using the Anxiety/ Somatization subitem of the Hamilton Depression Rating Scale. The association between WBC subset fraction and anxiety was evaluated. ResultsaaBasophil and eosinophil sub-fractions showed significant negative correlations with HAM-D anxiety/somatization factor scores (basophils: r=-0.092, p=0.014 and eosinophils: r=-0.075, p=0.046). When an anxiety score (a sum of somatic and psychic anxiety) was entered as a dependent variable, only basophils showed significant negative association with the anxiety scores after adjusting for all other WBC subset counts and demographic factors (t=-2.57, p=0.010). ConclusionaaThis study showed that anxious depression had a decreased basophil subfraction, which might be associated with involvement of inflammation in development of anxious depression.
Abstract
ObjectiveaaAnxious depression has a distinct neurobiology, clinical course and treatment response from non-anxious depression. Role of inflammation in anxious depression has not been examined. As an exploratory study to characterize the role of inflammation on a development of anxious depression, we aimed to determine the relationship between white blood cell (WBC) subset counts and anxiety in individuals with major depressive disorder (MDD). MethodsaaA total of 709 patients who were newly diagnosed with MDD were recruited. Anxiety levels of participants were evaluated using the Anxiety/ Somatization subitem of the Hamilton Depression Rating Scale. The association between WBC subset fraction and anxiety was evaluated. ResultsaaBasophil and eosinophil sub-fractions showed significant negative correlations with HAM-D anxiety/somatization factor scores (basophils: r=-0.092, p=0.014 and eosinophils: r=-0.075, p=0.046). When an anxiety score (a sum of somatic and psychic anxiety) was entered as a dependent variable, only basophils showed significant negative association with the anxiety scores after adjusting for all other WBC subset counts and demographic factors (t=-2.57, p=0.010). ConclusionaaThis study showed that anxious depression had a decreased basophil subfraction, which might be associated with involvement of inflammation in development of anxious depression.
참고문헌 (31)
- Ionescu DF, "Neurobiology of anxious depression : a review", Depress Anxiety, 30, pp.374~385 (2013)
- Fava M, "Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D", Psychol Med, 34, pp.1299~1308 (2004)
- Papakostas GI, "Severe and anxious depression : combining definitions of clinical sub-types to identify patients differentially responsive to selective serotonin reuptake inhibitors", Eur Neuropsychopharmacol, 22, pp.347~355 (2012)
- Altamura AC, "Does comorbid subthreshold anxiety affect clinical presentation and treatment response in depression? A preliminary 12-month naturalistic study", Int J Neuropsychopharmacol, 7, pp.481~487 (2004)
- Fava M, "What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder : a replication and extension", Can J Psychiatry, 51, pp.823~835 (2006)
- Maes M, "Leukocytosis, monocytosis and neutrophilia: hallmarks of severe depression", J Psychiatr Res, 26, pp.125~134 (1992)
- McAdams C, "Neutrophil and monocyte phagocytosis in depressed patients", Prog Neuropsychopharmacol Biol Psychiatry, 17, pp.971~984 (1993)
- Avlund K, "Differential associations between white blood cell counts and fatigue in young and older adults", Aging Clin Exp Res, 24, pp.439~447 (2012)
- Miller AH, "Inflammation and its discontents : the role of cytokines in the pathophysiology of major depression", Biol Psychiatry, 65, pp.732~741 (2009)
- Pasco JA, "Association of high-sensitivity C-reactive protein with de novo major depression", Br J Psychiatry, 197, pp.372~377 (2010)
- Reichenberg A, "Cytokine-associated emotional and cognitive disturbances in humans", Arch Gen Psychiatry, 58, pp.445~452 (2001)
- Berk M, "Aspirin : a review of its neurobiological properties and therapeutic potential for mental illness", BMC Med, 11, pp.74~ (2013)
- Hannestad J, "The effect of antidepressant medication treatment on serum levels of inflammatory cytokines : a metaanalysis", Neuropsychopharmacology, 36, pp.2452~2459 (2011)
- Baek JH, "Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder", Prog Neuropsychopharmacol Biol Psychiatry, 51, pp.113~118 (2014)
- Sheehan DV, "The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10", J Clin Psychiatry, 59(Suppl 20), pp.22~33 (1998)
- You SW, "The validation study of the Korean version of Mini-Interational Neuropsychiatric Interview", Anxiety Mood, 2, pp.50~55 (2006)
- Hamilton M, "Development of a rating scale for primary depressive illness", Br J Soc Clin Psychol, 6, pp.278~296 (1967)
- Rao S, "Anxious depression : clinical features and treatment", Curr Psychiatry Rep, 11, pp.429~436 (2009)
- Chirumbolo S, "State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve?", Blood Transfus, 10, pp.148~164 (2012)
- Ohtsu H, "Progress in allergy signal research on mast cells : the role of histamine in immunological and cardiovascular disease and the transporting system of histamine in the cell", J Pharmacol Sci, 106, pp.347~353 (2008)
- Senra MS, "Psychodermatological aspects of atopic dermatitis", Br J Dermatol, 170(Suppl 1), pp.38~43 (2014)
- Di Marco F, "Close correlation between anxiety, depression, and asthma control", Respir Med, 104, pp.22~28 (2010)
- Roth MK, "Effects of chronic plus acute prolonged stress on measures of coping style, anxiety, and evoked HPA-axis reactivity", Neuropharmacology, 63, pp.1118~1126 (2012)
- McCarty R, "Chronic stress and sympatheticadrenal medullary responsiveness", Soc Sci Med, 26, pp.333~341 (1988)
- Shahriari M, "Seeds of Arabidopsis plants expressing dominant-negative AtSKD1 under control of the GL2 promoter show a transparent testa phenotype and a mucilage defect", Plant Signal Behav, 5, pp.1308~1310 (2010)
- Toyoda M, "Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis", Br J Dermatol, 147, pp.71~79 (2002)
- Baldwin AL, "Mast cell activation by stress", Methods Mol Biol, 315, pp.349~360 (2006)
- Skaper SD, "Microglia and mast cells : two tracks on the road to neuroinflammation", FASEB J, 26, pp.3103~3117 (2012)
- Dere E, "Neuronal histamine and the interplay of memory, reinforcement and emotions", Behav Brain Res, 215, pp.209~220 (2010)
- Goodnick PJ, "Mirtazapine in major depression with comorbid generalized anxiety disorder", J Clin Psychiatry, 60, pp.446~448 (1999)
- Chikahisa S, "Histamine from brain resident MAST cells promotes wakefulness and modulates behavioral states", PLoS One, 8, pp.e78434~ (2013)